Table 2.
Symptoms at Baseline
| Rise-uP vs CG | |||||
|---|---|---|---|---|---|
| Rise-uP (N=930) | CG (N=307) | ||||
| M | SD | M | SD | Rise-uP vs CG (p) | |
| Pain Intensity (0–10) | 5.36 | 1.78 | 5.27 | 1.76 | n.s. |
| Anxiety (0–21) | 6.29 | 6.59 | 5.25 | 5.75 | n.s. |
| Depression (0–21) | 8.52 | 7.85 | 7.20 | 7.18 | n.s. |
| Stress (0–21) | 12.56 | 8.12 | 11.34 | 7.94 | n.s. |
| Functional ability (0% - 100%) | 71.0% | 19.8% | 77.1% | 19.1% | sig. |
|
Mental wellbeing (M = 50, SD = 10) |
44.94 | 11.15 | 47.11 | 11.15 | sig. |
| Physical wellbeing (M = 50, SD = 10)) | 40.30 | 8.69 | 42.79 | 8.67 | sig. |
| GCPS Grade 1 | 28% | 25% | n.s. | ||
| GCPS Grade 2 | 21% | 26% | |||
| GCPS Grade 3 | 47% | 43% | |||
| GCPS Grade 4 | 4% | 6% | |||
Notes: Means and SDs for the outcome parameters at T0 (baseline) for the Rise-uP group and the control group (all included patients). Bold numbers indicate Bonferroni-corrected (α’ = ·01) significance (two-tailed).